Search
for
Sort by
Research 571–600 of 1000+
- 0935 Unravelling the role of JAK3/TEC kinase signalling with ritlecitinib in alopecia areata lesional skin and alopecia areata-induced human hair follicles ex vivo
- Low Level Laser Treatment for Patterned Hair Loss: A Systematic Review
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Lrig1-expression confers suppressive function to CD4+ cells and is essential for averting autoimmunity via the Smad2/3/Foxp3 axis
- 41261 Identification of Demographic and Clinical Features Associated with Multi-Biologic Failure in the CorEvitas Psoriasis Registry
- Mite Burden and Immunophenotypic Response to <i>Demodex musculi</i> in Swiss Webster, BALB/c, C57BL/6, and NSG Mice
- Hair growth-stimulating effects of cyclosporin A and FK506, potent immunosuppressants
- New and Emerging Therapies for Alopecia Areata
- CD4+CD25+FoxP3+ Regulatory Tregs inhibit fibrocyte recruitment and fibrosis via suppression of FGF-9 production in the TGF-β1 exposed murine lung
- Poria cocos polysaccharides attenuate chronic nonbacterial prostatitis by targeting the gut microbiota: Comparative study of Poria cocos polysaccharides and finasteride in treating chronic prostatitis
- Immune therapies for alopecia areata: evidence and new perspectives
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Immortalized human hair follicle-derived mesenchymal-like stromal cells for the long-term production of scalable Immunomodulatory and regenerative secretome
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature
- 320 An open label clinical trial of Abatacept (CTLA4-Ig) for alopecia areata
- 046 Analysing the mechanistic basis of Ritlecitinib’s therapeutic effects in Alopecia Areata
- Exploring the Role of GLP‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review
- 52993 Regulatory γδ T cells protect human scalp hair follicles from alopecia areata in vivo
- 185 Regulatory γδ T cells protect human scalp hair follicles from alopecia areata in vivo
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- Tracing immune cells around biomaterials with spatial anchors during large-scale wound regeneration
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- 563 CsA-induced hypertrichosis might be caused in part by inhibition of TGF-β2 expression in dermal papilla cells.
- 004 Cell-based therapy may be effective in alopecia areata: Preclinical evidence that autologous, peripheral regulatory γdT cells are preventive in human ex vivo and therapeutic in human in vivo models
- Is knowledge about the genetic and epigenetic alterations in melanoma a basis for targeted therapy?
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Alopecia Areata: An Updated Review for 2023